
Merck will market Lipfendra, which is a first-of-its-kind pill that can reduce cholesterol in a way that’s previously only has been available with injectable drugs.

Merck will market Lipfendra, which is a first-of-its-kind pill that can reduce cholesterol in a way that’s previously only has been available with injectable drugs.